Company / Revenue per Share
Masimo Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$28.49
FY2025
5-year range
$5.41 / $36.81
FY2021-FY2025
Trend
+7.8%
vs FY2024
Sector context
#63 of 153
Health Care
What the data says
At $28.49, Masimo's revenue per share ranks #63 of 153 in the Health Care sector. Revenue per Share has fluctuated over the past 10 years, ranging from $5.41 in FY2021 to $36.81 in FY2022.
Based on SEC 10-K filings.
28.49 in FY2025 with a 5-year CAGR of +6.0%.
Improved from $24.30 to $28.49 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -8.2%
- 5-Year CAGR
- +6.0%
- 10-Year CAGR
- -
Sector benchmark
#63 of 153 in Health CareTop 41% of 153This company $28.49 Sector average $123.62
▼
-77.0% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 7.8% year-over-year.
- Ranks #63 out of 153 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2022.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Negative profit margin: -14.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.49 | +7.8% |
| FY2024 | $26.42 | +8.8% |
| FY2023 | $24.30 | -34.0% |
| FY2022 | $36.81 | +580.2% |
| FY2021 | $5.41 | -74.6% |
| FY2020 | $21.30 | +43.1% |
| FY2019 | $14.89 | +7.8% |
| FY2018 | $13.81 | -12.3% |
| FY2017 | $15.75 | +33.9% |
| FY2016 | $11.76 | +13.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026